Who is sponsoring NCT05727514?

NCT05727514 is sponsored by Brigham and Women's Hospital.

What drugs are being tested in NCT05727514?

Interventions in NCT05727514: music composition.

What condition does NCT05727514 study?

NCT05727514 studies Problems Related to Life-Management Difficulty.

Is NCT05727514 still recruiting?

NCT05727514 is currently completed. Last updated 8 March 2023.

Last reviewed 2023-03-08 · How we verify

NCT05727514

Name: Drug Landscape Pharmaceutical Database
Creator: Drug Landscape
Published: 2026-01-01
License: https://creativecommons.org/licenses/by/4.0/

Beyond COVID-19: Supporting Resilience With a Trauma-informed Music Composition Program

Completed NA Last updated 8 March 2023

What this trial tests

NA trial testing music composition in Problems Related to Life-Management Difficulty in 14 participants. Completed in 1 February 2023.

Timeline

22 April 2021

Primary endpoint
30 November 2022

1 February 2023

Quick facts

Lead sponsor	Brigham and Women's Hospital
Phase	NA
Status	Completed
Study type	INTERVENTIONAL
Allocation	na
Design	single group
Masking	none
Primary purpose	prevention
Enrollment	14
Start date	22 April 2021
Primary completion	30 November 2022
Estimated completion	1 February 2023
Sites	1 location across United States

Drugs / interventions tested

music composition

Conditions studied

Problems Related to Life-Management Difficulty — all drugs for Problems Related to Life-Management Difficulty →

Sponsor

Brigham and Women's Hospital

Who can join

Adults 18 to 60, any sex, with Problems Related to Life-Management Difficulty. Patients with the condition only — healthy volunteers not accepted.

Sponsor's own description

This study explores the feasibility and acceptability of a music composition intervention to support resilience in survivors of serious illness hospitalized during the COVID-19 pandemic.

Publications & conference data

No peer-reviewed publications indexed yet for this trial. Completed trials usually publish results within 12-18 months.

Verify or expand the search:

Other Brigham and Women's Hospital trials

Trials by the same sponsor.

NCT07011758 — Dynamic Treatment Regimes for Opioid Use Disorder · Phase 2 · not yet recruiting
NCT06310018 — Augmented Ultrasound-Facilitated, Catheter-Directed Fibrinolysis for PE · suspended
NCT04519177 — Randomized Trial of a Sleep Disorders Program on Firefighter Safety and Disability ... · NA · not yet recruiting
NCT06355986 — Computerized Decision Support to Prevent Stroke in Atrial Fibrillation · NA · not yet recruiting
NCT06099275 — Evaluation of Hemodynamics in People With Untreated Preeclampsia Using Echocardiography · suspended

Verify against primary sources

ClinicalTrials.gov — authoritative US registry record
WHO ICTRP — international registry index
EU Clinical Trials Register
Sponsor press releases (Google)

Data sources for this page

Trial protocol + status: ClinicalTrials.gov NCT05727514 (US National Library of Medicine, public domain)
Drug + disease cross-links: matched in real time against Drug Landscape's normalised drug + company + condition tables
Sponsor: as reported to ClinicalTrials.gov by Brigham and Women's Hospital
Last refreshed: 8 March 2023

Drug Landscape aggregates and links these public records for informational use only. Always verify against the primary source before clinical or regulatory decisions. Canonical URL: https://druglandscape.com/trial/NCT05727514.

Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing